BI-1935
Product Specifications
UNSPSC Description
BI-1935 is a potent soluble epoxide hydrolase (sEH) inhibitor. BI-1935 can be used for the research of cardiovascular disease[1].
Target Antigen
Epoxide Hydrolase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/bi-1935.html
Purity
98.01
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C(C=C1)=CN(CCOCC)C1=O)NC2=NC=C(N3N=C(C4=CC=CN=C4)C=C3C(F)(F)F)C=C2
Molecular Weight
498.46
References & Citations
[1]Roman Wolfgang Fleck, et al. Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors. WO2007067836A2.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-124063/BI-1935-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-124063/BI-1935-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
940954-41-6
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Yersinia pestis bv. Antiqua Xanthine phosphoribosyltransferase (gpt)